Oral premedication for the problem child: placebo and chloral hydrate. 1977

E S Barr, and R L Wynn, and R H Spedding

UI MeSH Term Description Entries
D007223 Infant A child between 1 and 23 months of age. Infants
D010919 Placebos Any dummy medication or treatment. Although placebos originally were medicinal preparations having no specific pharmacological activity against a targeted condition, the concept has been extended to include treatments or procedures, especially those administered to control groups in clinical trials in order to provide baseline measurements for the experimental protocol. Sham Treatment
D011292 Premedication Preliminary administration of a drug preceding a diagnostic, therapeutic, or surgical procedure. The commonest types of premedication are antibiotics (ANTIBIOTIC PROPHYLAXIS) and anti-anxiety agents. It does not include PREANESTHETIC MEDICATION. Premedications
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D002652 Child Behavior Any observable response or action of a child from 24 months through 12 years of age. For neonates or children younger than 24 months, INFANT BEHAVIOR is available. Behavior, Child
D002675 Child, Preschool A child between the ages of 2 and 5. Children, Preschool,Preschool Child,Preschool Children
D002697 Chloral Hydrate A hypnotic and sedative used in the treatment of INSOMNIA. Noctec,Hydrate, Chloral
D003729 Dental Care The total of dental diagnostic, preventive, and restorative services provided to meet the needs of a patient (from Illustrated Dictionary of Dentistry, 1982). Care, Dental
D004311 Double-Blind Method A method of studying a drug or procedure in which both the subjects and investigators are kept unaware of who is actually getting which specific treatment. Double-Masked Study,Double-Blind Study,Double-Masked Method,Double Blind Method,Double Blind Study,Double Masked Method,Double Masked Study,Double-Blind Methods,Double-Blind Studies,Double-Masked Methods,Double-Masked Studies,Method, Double-Blind,Method, Double-Masked,Methods, Double-Blind,Methods, Double-Masked,Studies, Double-Blind,Studies, Double-Masked,Study, Double-Blind,Study, Double-Masked
D004341 Drug Evaluation Any process by which toxicity, metabolism, absorption, elimination, preferred route of administration, safe dosage range, etc., for a drug or group of drugs is determined through clinical assessment in humans or veterinary animals. Evaluation Studies, Drug,Drug Evaluation Studies,Drug Evaluation Study,Drug Evaluations,Evaluation Study, Drug,Evaluation, Drug,Evaluations, Drug,Studies, Drug Evaluation,Study, Drug Evaluation

Related Publications

E S Barr, and R L Wynn, and R H Spedding
January 1962, Anesthesia and analgesia,
E S Barr, and R L Wynn, and R H Spedding
January 1962, Anesthesia and analgesia,
E S Barr, and R L Wynn, and R H Spedding
December 1984, Acta de odontologia pediatrica,
E S Barr, and R L Wynn, and R H Spedding
January 1984, Anesthesia progress,
E S Barr, and R L Wynn, and R H Spedding
March 1972, Lancet (London, England),
E S Barr, and R L Wynn, and R H Spedding
September 1967, Journal of dentistry for children,
E S Barr, and R L Wynn, and R H Spedding
January 1995, IARC monographs on the evaluation of carcinogenic risks to humans,
E S Barr, and R L Wynn, and R H Spedding
December 1893, The Journal of comparative medicine and veterinary archives,
Copied contents to your clipboard!